Login or Sign Up
Vivanza Biosciences Ltd. Financials
16:01 Jul 18
Vivanza Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Vivanza Biosciences Ltd.
Industry Pharmaceuticals
16:01 Jul 18
Quality
0/100
Not Eligible
Valuation
23/100
Expensive Valuation
Technical
34/100
Technically Bearish
Strength
2
Weakness
15
Opportunity
0
Threats
0
-17.00 %
ROE %
-4.09 %
ROA %
0.00
EPS
0.99
BVPS
-9.08 %
Net Profit Margin
| Mar 2023 | Mar 2024 | Mar 2025 | ||
|---|---|---|---|---|
| Net Sales | 17.81 | 27.84 | 7.42 | |
| Operating Expenses + | 17.15 | 26.77 | 7.79 | |
| Raw Material | 16.55 | 25.48 | 7.08 | |
| Increase Decrease in Cost | -0.05 | 0.47 | -0.26 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 0.35 | 0.45 | 0.58 | |
| Miscellaneous Expenses | 33.4 | 51.33 | 14.55 | |
| Operating Profit | 0.66 | 1.07 | -0.37 | |
| Other Income | 0.48 | 0.05 | 0.06 | |
| Depreciation | 0 | 0.01 | 0.01 | |
| Interest | 0.42 | 0.41 | 0.35 | |
| Profit before tax and exceptio.. | 0.72 | 0.7 | -0.67 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | 0.72 | 0.7 | -0.67 | |
| Provision for Taxation | 0.12 | 0.15 | 0.01 | |
| Net Profit | 0.6 | 0.55 | -0.67 | |
| NET Profit after MI | 0.6 | 0.55 | -0.67 | |
| EPS | 1.5 | 0.14 | -0.17 | |
| Operating Profit Margin (%) | 3.71 | 3.84 | -4.99 | |
| Net Profit Margin (%) | 3.37 | 1.98 | -9.03 |
Vivanza Biosciences Ltd. Shareholding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|
| Promoter | 20.00 | 20.00 | 20.00 | 39.90 | 40.00 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| MF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
